Article Text


Panencephalopathic type of Creutzfeldt-Jakob disease associated with cadaveric dura mater graft


A 52 year old man with Creutzfeldt-Jakob disease who received a cadaveric dura mater graft 99 months before the onset is reported. The prion protein gene was homozygous for methionine at the polymorphic codon 129. Neuropathological examination disclosed a panencephalopathic type of Creutzfeldt-Jakob disease which was characterised by severe involvement of the cerebral white matter and cerebellum, as well as of the cerebral cortical and deep grey matter. Thus the panencephalopathic type of Creutzfeldt-Jakob disease may occur in association with cadaveric dura mater grafts.

  • Creutzfeldt-Jakob disease
  • cadaveric dura matter graft
  • prion protein

Statistics from

Creutzfeldt-Jakob disease may develop associated with cadaveric dura mater grafts: since the first report by Thadani et al,1 there have been published reports of 19 cases of dural graft associated Creutzfeldt-Jakob disease (reviewed by Brown2 ). Clinically, most patients presented with ataxia, alone or in combination with visual symptoms or mental deterioration.2 However, neuropathological features of Creutzfeldt-Jakob disease associated with dural grafts is not fully understood. Clinical and neuropathological presentations of Creutzfeldt-Jakob disease would be influenced by several factors including the prion strain of contaminated dura mater grafts and polymorphism of the prion protein (PrP) gene of the host. Analyses of the neuropathological as well as clinical features would lead to better understanding of such factors.

We report another case of Creutzfeldt-Jakob disease after cadaveric dura mater graft, in which the neuropathology was of a panencephalopathic type.3 The neuropathological and clinicopathological features of the dural graft associated Creutzfeldt-Jakob disease are analysed together with a review of the literature.

Case report

The patient was a 52 year old man at the time of death. He underwent removal of a right frontal convexity meningioma on 24 December 1984, at the age of 43. A graft of cadaveric dura mater (Lyodura, B Braun Melsungen AG, Germany), was used, covering part of the right frontal lobe.

He stayed asymptomatic until March 1993 (99 months after surgery) when he complained of appetite loss, dysaesthesia of the throat, and blurred vision. On 5 April, during a game of golf, he suddenly developed ataxic gait and dysarthria. He became confused, and thereafter, mental deterioration rapidly progressed. He became bedridden on 22 April and was admitted to hospital. Neurologically, he showed akinetic mutism, paratonic rigidity of the limbs, exaggerated deep tendon reflexes, myoclonus, and startle reaction to auditory stimuli. Cranial CT was normal except for postoperative state of the right frontal area. His CSF was normal. On EEG, periodic synchronous discharge was found with generalised slowing. The clinical diagnosis was Creutzfeldt-Jakob disease. Cranial MRI in December disclosed diffuse brain atrophy with high intensity lesions of bilateral cerebral white matter in T2 weighted images (fig 1). He died of pneumonia on 21 January 1994 (10 months after the onset). Necropsy limited to the brain was performed 19 hours postmortem.

Figure 1

T2 weighted MRI nine months after onset of disease. There are bilateral diffuse high intensity lesions of the white matter and cortical atrophy in addition to the postoperative condition of the right frontal lobe (arrow).

The brain was 760 g in weight. The entire brain showed pronounced atrophy. There was an indentation in the right frontal convexity covered by a patch of dura mater graft. On section, the cerebral cortex was very thin, and the ventricles were enlarged. The striatum and thalamus showed brownish atrophy.

Histologically, the cerebral cortex diffusely showed considerable neuronal loss, proliferation of hypertrophic astrocytes, and spongy state or more pronounced destruction of the tissue (fig 2a). The deep grey matter showed the same changes: the striatum and medial nuclei of the thalamus were severely involved. Although the hippocampal formations were preserved compared with the neocortex, definitive spongiform changes could be seen in the subiculum (fig 2b). The cerebral white matter showed diffuse myelin pallor with proliferation of hypertrophic astrocytes and scattered foamy cells (fig 2c). Furthermore, there were several circumscribed lesions in the subcortical white matter (fig 2c). The circumscribed white matter lesions presented with a spongy appearance showing the vacuoles, foamy cells, loss of the myelinated fibres, and hypertrophic astrocytes (fig2d). In the cerebellum, the cortex showed pronounced atrophy with prominent fibrillary gliosis (fig 2e). A decrease of the granule cells was especially obvious, whereas Purkinje cells were relatively preserved in number. There were frequent formations of torpedoes in the granule cell layer (fig 2e). In the brainstem, a mild spongy state and astrocytic proliferation was found in the periaqueductal grey of the midbrain and pontine nuclei. There was mild degeneration of the pyramidal tracts with astrocytic proliferation.

Figure 2

Histological findings. (a) The frontal cortex shows a prominent loss of neuronal cells, many hypertrophic astrocytes, and spongy state of the tissue. (b) In the subiculum, spongiform changes are seen between the pyramidal cells. (c) The cerebral white matter shows diffuse myelin pallor (asterisk) and focal circumscribed lesions (arrows) in the subcortical areas. (d) With higher magnification, the circumscribed white matter lesions have a spongy appearance with proliferation of hypertrophic astrocytes and foamy cells. (e) In the cerebellar cortex, there is pronounced loss of the granule cells with severe fibrillary gliosis. Purkinje cells appear shrunken, but preserved in number; torpedoes (arrows) are often seen in the granule cell layer. (a, Luxol fast blue (LFB)-haematoxylin and eosin (HE), ×75; b, LFB-HE, ×256; c, LFB-HE ×1.6; d, LFB-HE, ×300; e, LFB-HE, ×99).

Immunohistochemistry for PrP was performed using an affinity purified rabbit polyclonal antibody to a synthetic peptide (amino acid sequence 95-108) of the PrP in the sections including the cerebral cortex, the white matter lesions, and the cerebellum from the patient, positive control tissues from a patient with Gerstmann-Sträussler-Scheinker’s disease associated with a codon 105 mutation,4 and negative control tissues from a patient with Alzheimer’s disease and from patients with no neurological disease. The cerebral (fig 3a and c) and cerebellar cortices (fig 3e) showed diffuse granular PrP immunostaining. Absorption of the antibody with the PrP peptide (amino acid sequence 95-108) before the immunohistochemistry completely blocked the immunostains (fig 3b, d, and f), showing the specificities of the immunoreactions. The changes in white matter including the circumscribed spongy lesions disclosed no definitive positive staining for PrP (fig 3g and h).

Figure 3

Immunohsitochemical findings with the anti-PrP antibody (a, c, e, g) and preabsorption of the antibody with the PrP peptide as negative controls (b, d, f, h) in the cerebral cortex (a-d), cerebellar cortex (e, f), and cerebral white matter lesion (g, h). The cerebral cortex (a) presents with diffuse PrP immunoreactivities showing granular appearance with higher magnification (c). In the cerebellar cortex (e), the intense granular stains were seen with relative sparing of the Purkinje cell layer. These positive immunoreactivities in the cerebral (a, c) and cerebellar cortices (e) were blocked by preabsorption of the antibody with the PrP peptide (b, d, f). The circumscribed cerebral white matter lesion, as indicated in fig 2d, shows no definitive PrP accumulation (g) compared with the negative control (h). (a, b, ×51; c, d, ×320; e, f, ×128; g, h, ×320)

Genomic DNA was extracted from the white blood cells. The open reading frame of the PrP gene was amplified and sequenced as previously described.4 There was no mutation in the open reading frame. Codon 129, a polymorphic site of the PrP gene, was homozygous for methionine.


The clinical features of our patient were consistent with the findings reported in the Lyodura-grafted cases of Creutzfeldt-Jakob disease including the time of surgical operations, incubation periods, neurological manifestations, and codon 129 homozygosity of the PrP gene.2

Neuropathologically, our patient presented with the panencephalopathic type of Creutzfeldt-Jakob disease. This type, first reported by Mizutani et al,3 is characterised by severe and extensive white matter lesions in addition to the typical spongiform changes of the cerebral cortex.3 The white matter changes include circumscribed spongy foci, which suggest primary involvement of the white matter.3 Severe cerebellocortical involvement of granular cell type is also found in the panencephalopathic type.3 In the PrP immunohistochemistry, we could find no definitive PrP accumulation in the white matter lesions, although the cerebral cortex and cerebellum showed the diffuse granular PrP immunostaining typical of Creutzfeldt-Jakob disease. Pathogenesis of the panencephalopathic type of Creutzfeldt-Jakob disease remains to be elucidated.

To delineate neuropathological characteristics of the dural graft associated disease, we reviewed the neuropathological findings for the six necropsied cases, in which distributions of the lesions were reported,5-10 and our patient (table).

Neuropathological findings of necropsied cases of Creutzfeldt-Jakob disease (CJD) after cadaveric dura mater grafts

All the patients showed spongiform change of the cerebral cortex. It should be noted that the cerebellar cortical involvement, affecting granule cells more than Purkinje cells, was found in all the cases of Creutzfeldt-Jakob disease associated with dural grafts. This is compatible with the common clinical presentation of ataxic symptoms in the cases associated with dural grafts, whereas in sporadic cases, about 10% of the patients had cerebellar ataxia alone when examined initially, or had cerebellar ataxia in association with an organic mental syndrome, and most of the ataxic cases showed neuropathologically severe cerebellar involvement.11Patients with Creutzfeldt-Jakob disease associated with peripheral injections of pituitary hormones derived from cadavers, the most frequent cause of iatrogenic transmission, stereotypically develop progressive cerebellar signs; pathologically, the cerebellar cortex is severely involved with or without Kuru plaques, whereas involvement of the cerebral cortex is milder.2 12 By contrast, both the cerebral and cerebellar cortex are severely involved in cases of Creutzfeldt-Jakob disease associated with dural grafts.

White matter lesions (loss of myelin and axons with proliferation of astrocytes and foamy cells) were reported in cases 59 and 610 (table); in those cases, however, there was no description of circumscribed focal lesion, as found in our case. Such focal lesions, in addition to diffuse involvement of the white matter, led to the neuropathological diagnosis of the panencephalopathic type of Creutzfeldt-Jakob disease3 in our case.

Kuru type amyloid plaques were described only in one exceptional case (5), in which cerebellar symptoms showed relatively slow progression, and the diagnosis was “idiopathic cerebellar degeneration”.9 In addition, very recently, “florid plaques” as found in a new variant of Creutzfeldt-Jakob disease was reported to be present in a biopsy tissue from a dura mater grafted case of Creutzfeldt-Jakob disease.13

In conclusion, we reported the panencephalopathic type of Creutzfeldt-Jakob disease associated with a cadaveric dura mater graft. The neuropathology was characterised by severe involvement of the white matter and cerebellum as well as of the cerebral cortical and deep grey matter. Further study is required to elucidate the clinicopathological range and pathogenesis of Creutzfeldt-Jakob disease associated with dural grafts.


We thank Dr Koba who referred the patient to us. We also thank Mr Isahai, Mr Takeda, Mr Konuma, and Ms Miura for their excellent technical assistance.


View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.